Ustar Biotechnologies (Hangzhou) Ltd. was established in 2005 and has been focused on the research, development, production, and sales of innovative point-of-care molecular diagnostic (POCT) technologies and products. The products and technologies have served over 3,000 medical institutions and are exported to more than 90 countries, actively contributing to the global control of major infectious diseases.